News Sentiment

PLSM sentiment intelligence

Pulsenmore Ltd. Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 3.82 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.0% over one week, +10.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Pulsenmore Expands Home Ultrasound Clinical Utility, Backed by New Clinical Evidence

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -1.0% Price digesting
Trend fit Trend inactive 10.7% over four weeks
Fair value -12.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 35
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
Market source 10
TradingView 6
Moomoo 3
Benzinga 3
Quiver Quantitative 2
Sahm 2
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 15
Deals and strategy 7
Regulatory and legal 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 52
The Norfolk Daily News Direct company coverage

Pulsenmore Expands Home Ultrasound Clinical Utility, Backed by New Clinical Evidence

Pulsenmore, a home ultrasound technology pioneer, announced new clinical evidence supporting the expansion of its home ultrasound platform for advanced prenatal assessments. Two independent peer-reviewed studies published in medical journals demonstrate the successful performance

Tone
Positive 95/100
Event
Market update
Published
16 Jul 2026 11:39
Source
The Norfolk Daily News
Stock Titan Direct company coverage

Pulsenmore (PLSM) completes $7.5M exempt warrant offering

Pulsenmore Ltd. (PLSM), an Israeli health care biotechnology company, has completed an exempt securities offering under Rule 506(b) of Regulation D, raising $7.5 million. The offering involved the sale of 1,562,500 pre-funded warrants and 1,562,500 ordinary warrants at $4.7999 ea

Tone
Neutral 50/100
Event
Market update
Published
16 Jul 2026 10:11
Source
Stock Titan
Stock Titan Direct company coverage

Pulsenmore Ltd. (PLSM) files to register 3.1M warrant shares for resale

Pulsenmore Ltd. (PLSM) has filed a resale prospectus to register 3.1 million ordinary shares for resale by a single selling shareholder, with these shares being issuable upon the exercise of warrants from a June 2026 private placement. The company will not receive proceeds from t

Tone
Negative 36/100
Event
Market update
Published
13 Jul 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Pulsenmore (NASDAQ: PLSM) chosen to lead $1M AI project for home ultrasound

Pulsenmore (NASDAQ: PLSM) has been selected by the Israel Innovation Authority and Ministry of Health to lead a $1 million AI development project. This project is part of Israel’s Healthcare AI Regulatory Sandbox Program and aims to develop and clinically validate AI applications

Tone
Positive 70/100
Event
Regulatory and legal
Published
13 Jul 2026 11:41
Source
Stock Titan
Pluang Direct company coverage

Pulsenmore joins Israel's AI Sandbox to develop AI for home ultrasound, boosting prenatal care efficiency.

Pulsenmore Ltd. has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program to develop and clinically validate AI applications for its home ultrasound platform. This initiative, supported by the Israel Innovation Authority and Ministry of Health, aims to

Tone
Neutral 50/100
Event
Regulatory and legal
Published
13 Jul 2026 11:41
Source
Pluang
Stock Titan Direct company coverage

Home ultrasound firm Pulsenmore to build AI tools in Israel’s $1M sandbox

Pulsenmore (NASDAQ: PLSM) has been chosen for Israel's Healthcare AI Regulatory Sandbox, receiving $1 million in funding from the Israel Innovation Authority to develop AI applications for its connected home ultrasound platform. These AI tools aim to enhance workflow efficiency a

Tone
Positive 66/100
Event
Regulatory and legal
Published
13 Jul 2026 10:41
Source
Stock Titan
Stock Titan Direct company coverage

[EFFECT] Pulsenmore Ltd. SEC Filing

Pulsenmore Ltd. (PLSM) has filed an EFFECT form with the SEC, which became effective on July 10, 2026, at 4:00 P.M. The filing indicates a neutral impact and sentiment. The article also provides recent news and other SEC filings related to Pulsenmore Ltd., as well as key stock da

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 10:41
Source
Stock Titan
Finviz Direct company coverage

PLSM - Pulsenmore Ltd Dividends

This article provides a detailed financial overview of Pulsenmore Ltd (PLSM), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance indicators like EPS, sales growth, insider/institutional ownership, an

Tone
Negative 39/100
Event
Earnings
Published
04 Jul 2026 09:09
Source
Finviz
Moomoo Direct company coverage

Pulsenmore Files Resale Registration for 3.1 Million Shares

Pulsenmore has filed a resale registration statement for approximately 3.1 million ordinary shares. This move typically allows existing shareholders to sell their shares to the public without the company issuing new ones. The filing signals a potential increase in the freely trad

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:39
Source
Moomoo
Stock Titan Direct company coverage

Armistice to resell 3.125M Pulsenmore shares (PLSM) via registered offering

Pulsenmore Ltd. (PLSM) is registering for resale 3.125 million ordinary shares, which are issuable upon the exercise of warrants from a June 2026 private placement. The selling shareholder, Armistice Capital Master Fund Ltd., will receive the proceeds from these resales, with Pul

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Pulsenmore (PLSM) cancels July AGM to revise compensation policy proposal

Pulsenmore Ltd. (PLSM) has canceled its Annual General Meeting of Shareholders previously scheduled for July 9, 2026, to revise Proposal 5, which concerns its Amended and Restated Compensation Policy. This decision follows discussions with shareholders to incorporate their feedba

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 21:40
Source
Stock Titan
Stock Titan Direct company coverage

Pulsenmore (PLSM) calls 2026 AGM to tighten executive pay and approve CEO bonus plan

Pulsenmore Ltd. (PLSM) has called its 2026 Annual General Meeting for August 6, 2026, where shareholders will vote on key corporate governance and compensation matters. The agenda includes re-electing Class I directors, approving a 2026 cash bonus plan for CEO Dr. Elazar Sonnensc

Tone
Neutral 50/100
Event
Balance sheet
Published
01 Jul 2026 21:40
Source
Stock Titan
TradingView Direct company coverage

Price to sales forward of Pulsenmore Ltd. – TASE:PLSM

This page provides financial information for Pulsenmore Ltd. (TASE:PLSM), specifically focusing on its forward price-to-sales ratio. The content indicates that market data is provided by ICE Data Services and FactSet, and SEC filings are sourced from Quartr.

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 04:11
Source
TradingView
Sahm Direct company coverage

Why Is Pulsenmore Stock Falling On Friday?

Pulsenmore Ltd. (NASDAQ: PLSM) stock fell in Friday's premarket session following an announcement of a $7.5 million private placement. The financing, which involves the sale of 1,562,500 ordinary shares and warrants, is intended to support the company's U.S. expansion and commerc

Tone
Negative 29/100
Event
Market update
Published
30 Jun 2026 19:10
Source
Sahm
TradingView Direct company coverage

Enterprise value to EBIT forward of Pulsenmore Ltd. – TASE:PLSM

This article provides financial information for Pulsenmore Ltd. (TASE:PLSM) directly from TradingView. It specifically highlights the company's enterprise value to EBIT forward. The data presented is for informational purposes for investors.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 14:12
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Pulsenmore Ltd. – TASE:PLSM

The article discusses the enterprise value to revenue forward for Pulsenmore Ltd. (TASE:PLSM), a packaged software company listed on the Tel Aviv Stock Exchange. It indicates specific product offerings and features available on the TradingView platform where this financial data i

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 13:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Pulsenmore Ltd. – TASE:PLSM

This article provides financial information for Pulsenmore Ltd. (TASE:PLSM), specifically focusing on its Enterprise Value to EBITDA forward metric. The data is available on TradingView, covering market, financial, news, and technical aspects for the company.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 03:04
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Pulsenmore Ltd. – TASE:PLSM

This article displays financial information for Pulsenmore Ltd. (TASE:PLSM), specifically its price to earnings forward data on TradingView. The content is primarily a data placeholder, indicating the company's financial metrics within the market.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 06:39
Source
TradingView
Moomoo Direct company coverage

Press Release: Pulsenmore Announces Pricing of $7.5 Million Private Placement With a Single Healthcare Focused Institutional Investor

Pulsenmore has announced the pricing of a $7.5 million private placement. This placement involves a single healthcare-focused institutional investor. The details of the transaction and its implications for the company are expected to be further elaborated.

Tone
Positive 70/100
Event
Market update
Published
26 Jun 2026 03:10
Source
Moomoo
Sahm Direct company coverage

Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States

Pulsenmore Ltd. and Ouma Health have announced a strategic partnership to expand access to remote prenatal care across the United States. Pulsenmore's FDA-authorized home ultrasound technology will be integrated into Ouma Health's virtual maternity care model, allowing clinicians

Tone
Positive 75/100
Event
Deals and strategy
Published
25 Jun 2026 16:40
Source
Sahm
TradingView Direct company coverage

Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor

Pulsenmore Ltd. announced the pricing of a $7.5 million private placement with a healthcare-focused institutional investor. The financing involves the sale of 1,562,500 ordinary shares (or pre-funded warrants) and ordinary warrants at $4.80 per share, intended to fund the company

Tone
Positive 70/100
Event
Market update
Published
25 Jun 2026 14:11
Source
TradingView
MSN Direct company coverage

Pulsenmore raises $7.5M in private placement; shares down

Pulsenmore has successfully raised $7.5 million through a private placement of ordinary shares. Despite this funding, the company's shares experienced a decline of 18%.

Tone
Negative 29/100
Event
Market update
Published
25 Jun 2026 12:52
Source
MSN
Stock Titan Direct company coverage

Pulsenmore raises $7.5M from healthcare investor

Pulsenmore (NASDAQ: PLSM) has priced a $7.5 million private placement with a single healthcare-focused institutional investor. The deal involves 1,562,500 ordinary shares (or pre-funded warrants) and warrants for an equal number of shares, all at a combined purchase price of $4.8

Tone
Positive 66/100
Event
Deals and strategy
Published
25 Jun 2026 11:41
Source
Stock Titan